Angela Yan

President, China, Asia Development & Operations at Kira Pharma

Ms. Yan joins Kira after over four years at Clinical CRO dMED-Clinipace, where she held a number of senior leadership positions including China President and Chief Operating Officer. She took full business responsibility in China and led operations and development efforts, building business management systems to increase operational efficiency and achieve sustainable growth. Prior to these roles, Ms. Yan served as Senior Director for R&D and Regulatory at R&D based Pharmaceutical Association Committee (RDPAC) in China, leading and engaging China R&D and Regulatory policy sharing to promote an innovation ecosystem and quality improvement, and supporting China to join ICH and becoming a member of ICH management committee. She also held several critical positions in global pharmaceutical companies including serving as the Regulatory Head for Asia Pacific, Millennium (Takeda Oncology) Asia Development Center, Regulatory Head for BMS China, and Regulatory Head of GSK China.

Location

San Francisco, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Kira Pharma

Kira Pharmaceuticals is a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases. Enabled by its proprietary LOGIC drug discovery platform, Kira is committed to advancing first-in-class and best-in-class therapies to patients around the world. The company is headquartered in Cambridge, Massachusetts with an R&D center in Suzhou, China.


Industries

Employees

11-50

Links